Pharmaceutical giant AstraZeneca said that the head of its China operations had been detained, after reports the firm was ...

AstraZeneca's price plunge following a fraud investigation in China could be just the time to buy AZN stock as big picture ...

Leon Wang, executive vice president in charge of China and the broader Asian region, is being detained while the Chinese ...

Chinese authorities detained the head of AstraZeneca’s China business last week, a move that threatens to dim foreign ...

And finally, its high-profile China president, Leon Wang, has been detained by authorities over the past week. AstraZeneca has told investors that it does not have clear visibility on the reasons.

UK pharma major AstraZeneca, which has invested heavily in China, hosted a sell-side analyst call on Wednesday (November 6) to discuss the recent media reports about ongoing investigations in China.

(Alliance News) - AstraZeneca PLC said Thursday that the head of its China operations had been detained, after reports the firm was under investigation for potentially illegal data collection and drug ...

Sarepta will discontinue its next generation of exon-skipping drugs for Duchenne muscular dystrophy over safety concerns, in ...

With an array of new medicines and medical devices on display, global medical companies are looking to tap further into the ...

AstraZeneca advances its ambition to redefine cancer care with new data across its ... Results will also be shared from the ChangE phase III trial, evaluating Calquence compared with chlorambucil plus ...

Jing'an also launched the "Quality Products Import Demonstration Zone", a strategic initiative aimed at strengthening its ...